142 related articles for article (PubMed ID: 15702232)
1. Histologic and genetic analysis of the gallbladder in patients with occult pancreatobiliary reflux.
Itoi T; Tsuchida A; Itokawa F; Sofuni A; Kurihara T; Tsuchiya T; Moriyasu F; Kasuya K; Serizawa H
Int J Mol Med; 2005 Mar; 15(3):425-30. PubMed ID: 15702232
[TBL] [Abstract][Full Text] [Related]
2. Assessment of occult pancreatobiliary reflux in patients with pancreaticobiliary disease by ERCP.
Itokawa F; Itoi T; Nakamura K; Sofuni A; Kakimi K; Moriyasu F; Tsuchida A; Aoki T
J Gastroenterol; 2004 Oct; 39(10):988-94. PubMed ID: 15549453
[TBL] [Abstract][Full Text] [Related]
3. K-ras point mutations in cancerous and noncancerous biliary epithelium in patients with pancreaticobiliary maljunction.
Matsubara T; Sakurai Y; Sasayama Y; Hori H; Ochiai M; Funabiki T; Matsumoto K; Hirono I
Cancer; 1996 Apr; 77(8 Suppl):1752-7. PubMed ID: 8608574
[TBL] [Abstract][Full Text] [Related]
4. Telomerase activity and Bcl-2 expression in gallbladders of pancreaticobiliary maljunction patients: a preliminary study.
Ichikawa Y; Kamiyama M; Sekido H; Ishikawa T; Miura Y; Kamiya N; Morita T; Shimada H
J Hepatobiliary Pancreat Surg; 2004; 11(1):34-9. PubMed ID: 15754044
[TBL] [Abstract][Full Text] [Related]
5. Clinical and genetic analysis of noncancerous and cancerous biliary epithelium in patients with pancreaticobiliary maljunction.
Nagai M; Watanabe M; Iwase T; Yamao K; Isaji S
World J Surg; 2002 Jan; 26(1):91-8. PubMed ID: 11898040
[TBL] [Abstract][Full Text] [Related]
6. p53 gene mutation and p53 protein overexpression in a patient with simultaneous double cancer of the gallbladder and bile duct associated with pancreaticobiliary maljunction.
Kasuya K; Nagakawa Y; Matsudo T; Ozawa T; Tsuchida A; Aoki T; Itoi T; Itokawa F
J Hepatobiliary Pancreat Surg; 2009; 16(3):376-81. PubMed ID: 19183832
[TBL] [Abstract][Full Text] [Related]
7. K-ras and p53 gene mutations in noncancerous biliary lesions of patients with pancreaticobiliary maljunction.
Matsubara T; Sakurai Y; Zhi LZ; Miura H; Ochiai M; Funabiki T
J Hepatobiliary Pancreat Surg; 2002; 9(3):312-21. PubMed ID: 12353142
[TBL] [Abstract][Full Text] [Related]
8. Intestinal metaplasia in gallbladder correlates with high amylase levels in bile in patients with a morphologically normal pancreaticobiliary duct.
Sakamoto H; Mutoh H; Ido K; Satoh S; Kumagai M; Hayakawa H; Tamada K; Sugano K
Hum Pathol; 2009 Dec; 40(12):1762-7. PubMed ID: 19716161
[TBL] [Abstract][Full Text] [Related]
9. Proliferative potential and K-ras mutation in epithelial hyperplasia of the gallbladder in patients with anomalous pancreaticobiliary ductal union.
Tanno S; Obara T; Fujii T; Mizukami Y; Shudo R; Nishino N; Ura H; Klein-Szanto AJ; Kohgo Y
Cancer; 1998 Jul; 83(2):267-75. PubMed ID: 9669809
[TBL] [Abstract][Full Text] [Related]
10. p53 and p21/Waf1 protein expression and K-ras codon 12 mutation in carcinoma of the papilla of Vater.
Zhao B; Kimura W; Futakawa N; Muto T; Kubota K; Harihara Y; Takayama T; Makuuchi M
Am J Gastroenterol; 1999 Aug; 94(8):2128-34. PubMed ID: 10445539
[TBL] [Abstract][Full Text] [Related]
11. Microvessel density, cyclo-oxygenase 2 expression, K-ras mutation and p53 overexpression in colonic cancer.
Liang JT; Huang KC; Jeng YM; Lee PH; Lai HS; Hsu HC
Br J Surg; 2004 Mar; 91(3):355-61. PubMed ID: 14991639
[TBL] [Abstract][Full Text] [Related]
12. Epithelial hyperplasia of the gallbladder in children with anomalous pancreaticobiliary ductal union.
Tanno S; Obara T; Fujii T; Mizukami Y; Yanagawa N; Izawa T; Ura H; Kohgo Y
Hepatogastroenterology; 1999; 46(30):3068-73. PubMed ID: 10626162
[TBL] [Abstract][Full Text] [Related]
13. Surgical treatment for non-dilated biliary tract with pancreaticobiliary maljunction should include excision of the extrahepatic bile duct.
Hara H; Morita S; Ishibashi T; Sako S; Dohi T; Iwamoto M; Tanigawa N
Hepatogastroenterology; 2001; 48(40):984-7. PubMed ID: 11490854
[TBL] [Abstract][Full Text] [Related]
14. Gallbladder carcinoma associated with occult pancreatobiliary reflux in the absence of pancreaticobiliary maljunction.
Inagaki M; Goto J; Suzuki S; Ishizaki A; Tanno S; Kohgo Y; Tokusashi Y; Miyokawa N; Kasai S
J Hepatobiliary Pancreat Surg; 2007; 14(5):529-33. PubMed ID: 17909727
[TBL] [Abstract][Full Text] [Related]
15. Different expression of cyclooxygenase-2 in biliary epithelia of bile duct cancer with or without pancreaticobiliary maljunction.
Watanabe O; Yoshimatsu K; Shiozawa S; Tsuchiya A; Oshibe N; Aiba M; Ogawa K
Anticancer Res; 2004; 24(2B):671-4. PubMed ID: 15161010
[TBL] [Abstract][Full Text] [Related]
16. Gallbladder mucosal lesions associated with high biliary amylase irrespective of pancreaticobiliary maljunction.
Free J; Wang F; Williams N; Gundara JS; Staerkle RF; Hugh TJ; Samra JS
ANZ J Surg; 2018 Jun; 88(6):E517-E521. PubMed ID: 28782883
[TBL] [Abstract][Full Text] [Related]
17. Relation between K-ras codon 12 mutation and p53 protein overexpression in gallbladder cancer and biliary ductal epithelia in patients with pancreaticobiliary maljunction.
Masuhara S; Kasuya K; Aoki T; Yoshimatsu A; Tsuchida A; Koyanagi Y
J Hepatobiliary Pancreat Surg; 2000; 7(2):198-205. PubMed ID: 10982614
[TBL] [Abstract][Full Text] [Related]
18. Occult pancreaticobiliary reflux in gallbladder cancer and benign gallbladder diseases.
Beltrán MA; Vracko J; Cumsille MA; Cruces KS; Almonacid J; Danilova T
J Surg Oncol; 2007 Jul; 96(1):26-31. PubMed ID: 17345616
[TBL] [Abstract][Full Text] [Related]
19. Frequent and significant K-ras mutation in the pancreas, the bile duct, and the gallbladder in autoimmune pancreatitis.
Kamisawa T; Tsuruta K; Okamoto A; Horiguchi S; Hayashi Y; Yun X; Yamaguchi T; Sasaki T
Pancreas; 2009 Nov; 38(8):890-5. PubMed ID: 19752775
[TBL] [Abstract][Full Text] [Related]
20. Recent advances in pancreaticobiliary maljunction.
Matsumoto Y; Fujii H; Itakura J; Matsuda M; Nobukawa B; Suda K
J Hepatobiliary Pancreat Surg; 2002; 9(1):45-54. PubMed ID: 12021897
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
